Status:
UNKNOWN
Study on Ex-PRESS Implantation Combined With Phacoemulsification in Primary Angle-closure Glaucoma
Lead Sponsor:
Wenzhou Medical University
Conditions:
Glaucoma, Angle-Closure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Primary angle-closure glaucoma (PACG) is common, phacotrabeculectomy is associated with a significant risk of complications.The Ex-PRESS shunt was introduced as a modification to trabeculectomy, with ...
Detailed Description
The Ex-PRESS is a miniature stainless steel glaucoma device, developed as an alternative to trabeculectomy mainly for patients with primary open-angle glaucoma.It has been proved to be as effective as...
Eligibility Criteria
Inclusion
- The presence of PACG, angle peripheral anterior synechia (PAS) more than 180 degrees.
- An indication for glaucoma filtering surgery based on uncontrolled IOP or progressive vision field defect despite antiglaucoma medications.
- Mean vision field defect greater than 15dB.
- The presence of a clinically significant decrease of visual acuity as a result of cataract, usually BCVA less than 0.6.
Exclusion
- Patients unable to give informed consent.
- Ocular infection or inflammation in the study eye in the 3 months prior to enrollment.
- Intraocular surgery in the study eye in the 3 months prior to enrollment.
Key Trial Info
Start Date :
July 1 2012
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 30 2018
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT03323138
Start Date
July 1 2012
End Date
December 30 2018
Last Update
October 26 2017
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Ophthalmology and Optometry Hospital , Wenzhou Medical University
Wenzhou, Zhejiang, China, 325027